Participants
Contact
Several media echo the concession of € 90,000 by Acció—the economic development agency of the Catalan government—to IRB group leader Roger Gomis. The funding will be used to develop new markers for the diagnosis of bone metastases.
Read this news in Expansión (PDF in Spanish)
Read this news in other media:
Gaceta Médica (PDF)
Europa Press (PDF)
La información (PDF)
Emprendia (PDF)
Related news
5 March 2014
IRB to develop an innovation project on bone metastasis
About IRB Barcelona
The Institute for Research in Biomedicine (IRB Barcelona) pursues a society free of disease. To this end, it conducts multidisciplinary research of excellence to cure cancer and other diseases linked to ageing. It establishes technology transfer agreements with the pharmaceutical industry and major hospitals to bring research results closer to society, and organises a range of science outreach activities to engage the public in an open dialogue. IRB Barcelona is an international centre that hosts 400 researchers and more than 30 nationalities. Recognised as a Severo Ochoa Centre of Excellence since 2011, IRB Barcelona is a CERCA centre and member of the Barcelona Institute of Science and Technology (BIST).
